MIRA INFORM REPORT

 

 

Report Date :

06.01.2011

 

Note: Given address Could not be confirmed.

 

IDENTIFICATION DETAILS

 

Name :

PAREXEL INTERNATIONAL SYNCHRON PRIVATE LIMITED

 

 

Registered Office :

3rd Floor, Mfar Silverline Tech Park, Plot 180, EPIP II Phase, Whitefield, Bangalore-560066, Karnataka

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

24.04.2006

 

 

Com. Reg. No.:

039077

 

 

CIN No.:

[Company Identification No.]

U74220KA2006PTC039077

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Providing Clinical Research Services.

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 229324

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION DENIED BY

 

Name :

Mr. Arvind

Designation :

Accounts Manager

Date :

04.01.2011

 

LOCATIONS

 

Registered Office :

3rd Floor, Mfar Silverline Tech Park, Plot 180, EPIP II Phase, Whitefield, Bangalore-560066, Karnataka, India

Tel. No.:

91-80-25430095

Fax No.:

91-80-25430096

E-Mail :

Suresh.reddy@parexel.com

 

 

DIRECTORS

 

As on 30.09.2010

Name :

Mr. James Francis Winschel Jr.

Designation :

Director

Address :

11 Cudworth Lane, Sudbury, US

Date of Birth/Age :

27.06.1949

Date of Appointment :

15.06.2006

 

 

Name :

Mr. Josef Hieronymus Rickenbach

Designation :

Director

Address :

28 Brent Road, Lexington, US

Date of Birth/Age :

10.11.1954

Date of Appointment :

15.06.2006

 

 

Name :

Mr. Parvathareddy Suresh Kumar Reddy

Designation :

Additional Director

Address :

Flat 304, Block IV, Rajapushpa Silicon Ridge Attapur, Hyderabad-500036, Andhra Pradesh, India

Date of Birth/Age :

10.07.1974

Date of Appointment :

24.11.2009

 

 

KEY EXECUTIVES

 

Name :

Mr. Arvind

Designation :

Accounts Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2010

 

Names of Shareholders

 

No. of Shares

Parexel International Holding BV, Netherlands

 

39999

Parexel International (India) Private Limited, India

 

1

Total

 

40000

 

As On 30.09.2010

Category

Percentage

Foreign holdings( Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others

99.99

Bodies corporate

0.01

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Providing Clinical Research Services.

 

 

GENERAL INFORMATION

 

No. of Employees :

Denied by Management

 

 

Bankers :

Not Available

 

 

Facilities :

--

 

Banking Relations :

--

 

 

Auditors :

 

Name :

S V Ghatalia And Associates

Chartered Accountant

Address :

12th Floor, Canberra Block, UB City, Vittal Mallya Road, Bangalore-560001, Karnataka, India

Tel. No.:

91-80-40275000

Fax No.:

91-80-22106000

 

 

Holding Company :

Parexel International Holdings BV, Netherlands

 

 

Fellow Subsidiaries :

  • Parexel International Limited, United Kingdom
  • Parexel International GMBH, Germany
  • BVUD Research (India) Private Limited, India
  • Parexel International LLC, USA
  • Parexel International Co Limited, Taiwan
  • Parexel International India Private Limited, India

 

 

CAPITAL STRUCTURE

 

AS ON 31.03.2010

Authorised Capital :

No. of Shares

Type

Value

Amount

1000000

Equity Shares

Rs.10/- each

Rs.10.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

40000

Equity Shares

Rs.10/- each

Rs.0.400 Million

 

Note: Of the above 30000 shares are held by Parexel International Holdings BV, Netherlands, the Holding Company

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.400

0.400

0.400

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

56.931

27.592

12.502

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

57.331

27.992

12.902

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

0.000

0.000

0.000

TOTAL BORROWING

0.000

0.000

0.000

DEFERRED TAX LIABILITIES

0.000

0.301

0.000

 

 

 

 

TOTAL

57.331

28.293

12.902

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

8.648

11.796

3.634

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

1.666

0.000

0.692

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

0.000

0.000

0.000

 

Sundry Debtors

41.261

12.007

0.000

 

Cash & Bank Balances

90.075

15.296

34.288

 

Other Current Assets

2.056

3.339

0.000

 

Loans & Advances

10.764

11.628

3.939

Total Current Assets

144.156

42.270

38.227

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

6.168

4.960

10.043

 

Other Current Liabilities

88.023

20.723

17.972

 

Provisions

2.948

0.090

1.636

Total Current Liabilities

97.139

25.773

29.651

Net Current Assets

47.017

16.497

8.576

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

57.331

28.293

12.902

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

 

 

Income from services

320.286

193.838

85.864

 

 

Other Income

0.000

0.000

0.000

 

 

TOTAL                                     (A)

320.286

193.838

85.864

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Clinical Research Costs

213.558

133.761

55.457

 

 

Personnel Expenses

23.168

14.839

6.299

 

 

Operating And Other Expenses

33.742

15.814

8.120

 

 

TOTAL                                     (B)

270.468

164.414

69.876

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

49.818

29.424

15.988

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

49.818

29.424

15.988

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

4.445

3.141

2.228

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

45.373

26.283

13.760

 

 

 

 

 

Less

TAX                                                                  (I)

16.034

11.193

6.446

 

 

 

 

 

 

PROFIT AFTER TAX (G-I)                                  (J)

29.339

15.090

7.314

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

23.892

8.802

1.355

 

 

 

 

 

Add

Adjustment for Transistional provision under AS 15

0.000

0.000

0.133

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

53.231

23.892

8.802

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

320.286

193.838

85.864

 

TOTAL EARNINGS

 

 

 

 

 

 

 

 

 

Earnings Per Share (Rs.)

733.00

--

--

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

9.16

7.78

8.51

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

14.16

13.55

16.02

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

29.69

48.61

32.87

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.79

0.93

1.06

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.69

0.92

2.29

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.48

1.64

1.28

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Note:

The registered office address has been shifted from 2nd Floor, No 4M 413 III, Block, Hennur BAnaswadi Road, Bangalore-560043, Karnataka, India to present w.e.f. 01.01.2009.

 

Sundry Creditors Details:

(Rs. In Millions)

 

Particulars

31.03.2010

31.03.2009

31.03.2008

Sundry Creditors

6.168

4.960

10.043

 

 

Fixed Assets:

 

  • Lease Hold Improvements
  • Computers
  • Furniture And Fittings
  • Office Equipment
  • Software

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.20

UK Pound

1

Rs.70.27

Euro

1

Rs.59.99

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

New Business

                                      

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.